Merit Medical Systems, Inc. · NASDAQ:MMSI
Merit Medical Systems — Q3 2016 Earnings Presentation
11 slides from Merit Medical Systems's earnings presentation, Oct 26, 2016
Slide 1: 3rd Quarter 2016 Results
1 3rd Quarter 2016 Results FRED LAMPROPOULOS Chairman & CEO BERNARD BIRKETT CFO Exhibit 99.2
Slide 2: Disclosure Regarding Forward-Looking Statements
2 DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes “forward-looking statements” as defined within applicable securities laws and regulations. All statements in this presentation, other than statements of historical fact, are “forward-looking statements”, including projectio
Slide 3: Financial Summary GAAP
3 Financial Summary GAAP Q3 2016 Q3 2015 2016 YTD 2015 YTD Revenue $157.0M $136.1M $446.1M $403.7M Gross Margin 43.2% 43.5% 43.7% 43.5% Net Income $1.0M $4.8M $12.6M $17.4M EPS $0.02 $0.11 $0.28 $0.39
Slide 4: Financial Summary Non-GAAP
4 Financial Summary Non-GAAP Q3 2016 Q3 2015 2016 YTD 2015 YTD Revenue (Constant Currency) $158.1M $136.1M $449.8M $403.7M Revenue (Reported) $157.0M $136.1M $446.1M $403.7M Gross Margin 46.8% 45.6% 46.4% 45.5% Net Income $11.5M $8.9M $31.4M $27.8M EPS $0.26 $0.20 $0.70 $0.62
Slide 5: Q3 2016 Revenue by Market
5 Q3 2016 Revenue by Market United States 61.4% Other International 20.8% EMEA 17.8% Q3 2016 Revenue by Market 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% United States EMEA Other International 13.1% 23.5% 19.5% Revenue Growth in Constant Currency: Q3 2016 to Q3 2015
Slide 6: 6
6
Slide 7: Q3 2016 Highlights
7 Q3 2016 Highlights • Completed enrollment in EVOLVE study • 510(k) clearance for Elation® Pulmonary Dilation Balloon • Launched Super HERO® and HeRO Ally™ products • Integration of DFINE, Inc. (closed July 6, 2016) • Launched basixTOUCH40™Inflation Device
Slide 8: Growth Drivers
8 Growth Drivers • New Products - HeRO® Graft - Corvocet™ Biopsy Device - SwiftNINJA® Steerable Microcatheter - Pedal Access - Micropuncture - Centesis Catheters - Amplatz Guide Wires - basixTOUCH40™ Inflation Device - Prelude® SNAP Hydrophilic - Wire Guided & Pulmonary Balloons • Wholesale to Retai
Slide 9: 2016 Guidance
9 2016 Guidance Revenues $603.5M - $613.5M Gross Margin GAAP 43.7% - 44.7% Gross Margin Non-GAAP 46.5% - 47.5% EPS GAAP $0.45 - $0.51 EPS Non-GAAP $0.97 - $1.03
Slide 10: Disciplined, customer-focused enterprise
10 1 2 3 4 Disciplined, customer-focused enterprise Guided by strong core values to globally address unmet or underserved healthcare needs Target high-growth, high-return opportunities Through understanding, innovating, and delivering in peripheral, cardiac, OEM, and endoscopy business lines Optimiz
Slide 11: 11
11
Merit Medical Systems — Q3 2016 Earnings Presentation on 6ix